| Breakdown | Mar 2026 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.53B | 1.33B | 1.22B | 1.10B | 903.70M |
| Gross Profit | 934.00M | 917.40M | 815.20M | 733.60M | 554.00M |
| EBITDA | 220.30M | 244.30M | 236.50M | 263.70M | 190.70M |
| Net Income | 22.50M | 58.40M | 72.70M | 94.60M | 70.30M |
Balance Sheet | |||||
| Total Assets | 1.75B | 1.48B | 1.59B | 1.34B | 1.51B |
| Cash, Cash Equivalents and Short-Term Investments | 408.20M | 144.90M | 286.50M | 287.70M | 477.90M |
| Total Debt | 785.20M | 728.40M | 754.00M | 620.70M | 622.60M |
| Total Liabilities | 1.13B | 1.06B | 1.11B | 912.70M | 907.10M |
| Stockholders Equity | 608.40M | 417.00M | 469.50M | 427.90M | 600.10M |
Cash Flow | |||||
| Free Cash Flow | 141.40M | 108.10M | 68.20M | 114.40M | 261.70M |
| Operating Cash Flow | 191.90M | 164.60M | 116.30M | 151.60M | 293.70M |
| Investing Cash Flow | -50.50M | -72.40M | -45.30M | -37.20M | -32.00M |
| Financing Cash Flow | -70.10M | -232.80M | -80.70M | -298.20M | 197.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | C$152.08M | 2.06 | 3.16% | ― | 5.61% | ― | |
75 Outperform | C$15.99B | 36.39 | 30.33% | ― | 35.21% | 80.50% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | C$14.39B | -39.84 | 10.09% | 1.47% | 23.06% | -33.83% | |
54 Neutral | C$100.31M | -121.63 | -0.06% | ― | 0.40% | -108.80% | |
53 Neutral | C$1.28B | 65.91 | 4.29% | ― | 13.14% | -76.53% | |
53 Neutral | C$5.59B | 39.24 | 54.95% | 0.86% | 6.51% | ― |